Evaluation of antibacterial activity and the mechanism of naringenin against Mycoplasma synoviae
Frontiers in Cellular and Infection Microbiology · 18.11.2026 · 16
DOI: 10.3389/fcimb.2026.1942943 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 18.11.2026. Verfasst von Qiao Hu und 11 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The global antibiotic resistance crisis has fueled a demand for promising novel alternatives. Naringenin, a type of traditional Chinese medicine, is known for its anti-tumor, anti-inflammatory, and antibacterial activities. However, the inhibitory effect of naringenin on Mycoplasma has not yet been established. Herein, we reported that naringenin effectively inhibited various mycoplasmas. Using Mycoplasma synoviae ( M. synoviae ) as a model, naringenin inhibited cell growth, biofilm formation, cell division, and increased reactive oxygen species (ROS) production. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of naringenin against M. synoviae was identified as 125 and 250 µg/mL, respectively. Dose-dependent inhibition effect of naringenin on the growth of M. synoviae . The anti-biofilm effect of naringenin was confirmed using crystal violet staining and laser confocal microscopy. Scanning electron microscopy showed that both cell length and width were significantly reduced, and the length/width ratio was significantly increased, indicating that cell morphology changed from spherical to rod-shaped upon treatment with naringenin. RT-qPCR analysis showed a significant reduction in the expression of genes involved in biofilm formation ( eno , gap , and pdhD ) and cell division ( ftsZ , stk , ftsH , and wihA ) after culturing with 1/2×MIC of naringenin. Another possible anti-mycoplasma mechanism is that naringenin markedly increased intracellular ROS levels and significantly reduced SOD activity, whereas POD, CAT, and GSH were not significantly affected. Collectively, these results demonstrate that naringenin exerts anti-mycoplasma effects by inhibiting M. synoviae cell growth, biofilm formation, and cell division, while simultaneously inducing oxidative damage.
Zitieren
APA
Hu, Q., Lu, Q., Guo, Y., Cao, X., Liu, J., Zhang, W., Zhang, R., Yang, B., Zheng, P., Zhou, P., Zhang, T., & Luo, Q. (2026). Evaluation of antibacterial activity and the mechanism of naringenin against Mycoplasma synoviae. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1942943
Vancouver
Hu Q, Lu Q, Guo Y, Cao X, Liu J, Zhang W, et al. Evaluation of antibacterial activity and the mechanism of naringenin against Mycoplasma synoviae. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1942943
BibTeX
@article{Hu2026,
author = {Hu, Qiao and Lu, Qin and Guo, Yunqing and Cao, Xiaoyi and Liu, Jiaying and Zhang, Wenting and Zhang, Rongrong and Yang, Bokai and Zheng, Peipei and Zhou, Ping and Zhang, Tengfei and Luo, Qingping},
title = {Evaluation of antibacterial activity and the mechanism of naringenin against Mycoplasma synoviae},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1942943}
}
EUVIMED